Deferasirox Tablet, Film Coated
Product Images NDC 31722-013

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 31722-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

180mg-30count (180mg 30count)

Label for Deferasirox 180 mg film-coated tablets, manufactured by Camber Pharmaceuticals, Inc. The label indicates this is an oral prescription medication with 30 tablets per container. It includes storage instructions, a pharmacist dispensing note, and manufacturer details for Annora Pharma Pvt. Ltd., India. The label also features a barcode and contact information for medication guides.*

FDA Label Image

360mg-30count (360mg 30count)

Label for Deferasirox Tablets 360 mg, film-coated oral tablets by Camber Pharmaceuticals, Inc. The label indicates a package size of 30 tablets. It includes dosage storage instructions, a pharmacist dispensing note, and contact information for U.S. inquiries. Manufactured by Annora Pharma Pvt. Ltd., India, for Camber Pharmaceuticals.*

FDA Label Image

90mg-30count (90mg 30count)

Deferasirox 90 mg tablets film-coated label by Camber Pharmaceuticals, Inc. The label highlights 90 mg per tablet strength, a package count of 30 tablets, and usage instructions including storage temperatures and moisture protection. It notes dispensing a medication guide for pharmacists. Manufactured by Annora Pharma Pvt. Ltd., Telangana, India, for Camber Pharmaceuticals, Piscataway, NJ.*

FDA Label Image

Apistructure (Apistructure)

Chemical structure of Deferasirox, showing the molecular framework with specific functional groups including hydroxyl and carboxyl groups attached to aromatic rings.*

FDA Label Image

Camber (Camber)

FDA Label Image

Figure1 (Figure1)

A bar chart depicting the changes in liver iron content (LIC) in mg Fe/g dry weight and serum ferritin levels in ng/mL in response to different doses of Deferasirox in mg/kg/day. The x-axis shows Deferasirox doses ranging from 5 to 30 mg/kg/day, while the y-axes represent changes in LIC (left) and serum ferritin (right). Bars distinguish between liver iron content and serum ferritin changes at each dose level.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.